Chemically Defined Media for Antibody Color Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing proteins in recombinant cell cultures face challenges in achieving acceptable quality attributes, particularly color intensity, especially at high concentrations like ≥150 mg/mL, due to the use of chemically undefined media components which lead to lot-to-lot variability and contamination issues.
Innovation Solution
Development of chemically defined cell culture media (CDM) compositions containing specific components such as cystine, vitamins (B2, B6, B9, B12), an iron source, and hydrocortisone to modulate protein product quality attributes, reducing color intensity and maintaining desired protein concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemically undefined media components (animal sera, peptone) are used for protein production, then cell growth and protein production are maintained, but lot-to-lot variability and contamination with undesirable constituents occur
Solution Approach 1:
The patent applies parameter changes by transitioning from chemically undefined media to chemically defined media with precisely controlled compositions. Specific parameters including amino acid concentrations (0.8-2.5 mM cystine), vitamin levels (B2, B6, B9, B12), iron sources, and hydrocortisone are optimized to maintain high protein production while eliminating batch variability and contamination risks associated with animal-derived components
2Quantity of substance
If protein concentration is increased to ≥150 mg/mL for subcutaneous delivery, then drug efficacy is improved, but color intensity becomes more intense making it difficult to meet regulatory requirements
Solution Approach 1:
The patent employs parameter changes by optimizing media composition parameters to produce proteins with reduced color intensity even at high concentrations. Specific adjustments include cystine concentration (0.8-2.5 mM), vitamin B levels, iron source optimization, and hydrocortisone addition, which collectively enable production of ≥150 mg/mL protein formulations while maintaining acceptable color characteristics for subcutaneous injection
Solution Approach 2:
The patent converts the potential harm of high protein concentration (which normally intensifies color) into a benefit by using optimized chemically defined media that produces proteins with inherently lower color intensity. This allows the high concentration needed for subcutaneous efficacy to be achieved without the detrimental color intensification that would normally accompany such concentration increases
3Reliability
If chemically defined media are used to eliminate variability, then product consistency is improved, but media composition optimization becomes more complex
Solution Approach 1:
The patent manages media composition complexity by systematically optimizing specific parameters within defined ranges rather than attempting complete control of all media components. Key parameters include cystine (0.8-2.5 mM), vitamins B2/B6/B9/B12, iron sources, and hydrocortisone, with each parameter optimized to contribute to overall product consistency while maintaining practical manufacturability
Data Source
AI summary
Cell culture media, such as chemically defined cell culture media, are provided, as are methods of using the media for cell growth (i.e., cell culture) and polypeptide (e.g., antibody) production. Compositions comprising polypeptides produced by the methods are also provided.